Current status of endoscopic stenting of the pancreatic duct as prophylaxis against post-ERCP pancreatitis

Gastroenterology and Hepatology

Volumn 8, Issue 9, 2012, Pages 618-620

  Freeman, Martin L ^a,b,c  

^a Deparment of Medicine   (United States)

^b Total Pancreatectomy and Islet Autotransplantation ^*  (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; INDOMETACIN;

BALLOON DILATATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGH RISK PATIENT; HUMAN; LAW SUIT; LOW RISK POPULATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALPRACTICE; META ANALYSIS (TOPIC); MONOTHERAPY; MULTICENTER STUDY (TOPIC); NOTE; PANCREAS DIVISUM; PANCREAS DUCT; PANCREATITIS; PATIENT CARE; PATIENT SAFETY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SPHINCTEROTOMY; STENT; TERTIARY HEALTH CARE; VATER PAPILLA STENOSIS;

EID: 84868005861     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414-1422.
2. Dumonceau JM, Rigaux J, Kahaleh M, Gomez CM, Vandermeeren A, Devière J. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc. 2010;71:934-939, 939.e1-2.
3. Freeman ML. Pancreatic stents for prevention of post-ERCP pancreatitis: for everyday practice or for experts only? Gastrointest Endosc. 2010;71:940-944.
4. Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1354-1365.